Press releases

Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its ZIPwire™ Hydrophilic Guide Wire, which has received clearance...

Boston Scientific Corporation (NYSE: BSX) welcomed recent results from studies presented at the annual American College of Cardiology Scientific...

Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court judge in Delaware has denied the Company's motion to overturn...

Boston Scientific Corporation (NYSE: BSX) today announced that it has made certain commitments to the Directorate-General for Competition of the...

Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that Institutional Shareholder...

Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V ISR...

Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from its ARRIVE II registry, confirming the...

Boston Scientific Corporation (NYSE: BSX) today welcomed results from the independent, multi-center STENT registry, the largest...

Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS V ISR (in-stent restenosis) clinical...

Boston Scientific Corporation (NYSE: BSX) today announced that it plans to name a leadership team for its new Cardiac Rhythm Management (CRM)...

Boston Scientific Corporation (NYSE: BSX) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the annual American College of Cardiology...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 9th Annual Lehman Brothers 2006 Global Healthcare Conference, which is...

Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Securities and Exchange...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 26th Annual Health Care Conference, which is being held...

(February 15, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS

(February 6, 2006)

(February 3, 2006) Boston Scientific Corporation (NYSE: BSX) today issued the following statement on a meeting between senior officials of the Company and senior officials of the U.S. Food and...

(February 1, 2006) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2006 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...

(January 31, 2006) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2005 on...

(January 26, 2006)

and Indianapolis, IN (January 25, 2006)

(January 23, 2006)

(January 18, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced the results of a five-year retrospective study on Peripherally Inserted Central Catheters (PICCs) with Pressure...

(January 17, 2006)

(January 17, 2006)

(January 11, 2006)

(January 9, 2006)

(January 8, 2006)

(January 8, 2006)

(January 5, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin has agreed to a request from the Board of Directors to extend...

(January 4, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a transitional...

(February 7, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005. 2005 HIGHLIGHTS Net sales of $6.283...

(December 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced it has made a $250,000 gift to Doctors Without Borders, an international medical humanitarian organization, in...

(December 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced a $500,000 contribution to the University of Minnesota Foundation to fund the creation of a Boston Scientific...

(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all Flextome Cutting Balloon

(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been recognized with the American Red Cross

(December 7, 2005)

(December 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that two of its senior executives are scheduled to participate in the first annual Massachusetts Conference for...

(December 5, 2005)

(November 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday,...

(November 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $750 million aggregate principal amount of its senior notes under the Company

(November 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $750 million aggregate principal amount of its senior notes under the Company

(November 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, randomized,...

and Vancouver, B.C. (November 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) announced today that they have jointly received the...

(November 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a new series of...

(October 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Sixteenth Annual Healthcare Conference, which is being held November 7-9 in...

(October 25, 2005)

(October 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has acquired a portfolio of proprietary endoscopic stent technologies from Willy Rüsch GmbH (Rüsch), a...

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from the transitional phase of its OLYMPIA registry. The OLYMPIA registry is...